Altium Wealth Management »

Regeneron Pharmaceuticals shares owned by Altium Wealth Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Altium Wealth Management from 13F filings

Historical chart of Altium Wealth Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Altium Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Altium Wealth Management

Quarter filed Position value Share count Share price at filing
2022-06-30 $591k 999 591.59

More positions owned by Altium Wealth Management

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Core Msci Emkt (IEMG)
Vanguard Tax-managed Intl Van Ftse Dev Mkt (VEA)
Apple (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Admiral Fds 500 Grth Idx F (VOOG)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Microsoft Corporation (MSFT)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)

View all positions for Altium Wealth Management

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals